IL136604A0 - Oromucosal cytokine compositions and uses thereof - Google Patents

Oromucosal cytokine compositions and uses thereof

Info

Publication number
IL136604A0
IL136604A0 IL13660498A IL13660498A IL136604A0 IL 136604 A0 IL136604 A0 IL 136604A0 IL 13660498 A IL13660498 A IL 13660498A IL 13660498 A IL13660498 A IL 13660498A IL 136604 A0 IL136604 A0 IL 136604A0
Authority
IL
Israel
Prior art keywords
oromucosal
cytokine compositions
cytokine
compositions
oromucosal cytokine
Prior art date
Application number
IL13660498A
Other languages
English (en)
Original Assignee
Pharma Pacific Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Pacific Pty Ltd filed Critical Pharma Pacific Pty Ltd
Publication of IL136604A0 publication Critical patent/IL136604A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/212IFN-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/20Interleukins [IL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/215IFN-beta
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL13660498A 1997-10-10 1998-10-09 Oromucosal cytokine compositions and uses thereof IL136604A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9712687A FR2769505B1 (fr) 1997-10-10 1997-10-10 Compositions de cytokines a administrer a la muqueuse buccale, et leurs utilisations
PCT/IB1998/001720 WO1999018992A1 (en) 1997-10-10 1998-10-09 Oromucosal cytokine compositions and uses thereof

Publications (1)

Publication Number Publication Date
IL136604A0 true IL136604A0 (en) 2001-06-14

Family

ID=9512087

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13660498A IL136604A0 (en) 1997-10-10 1998-10-09 Oromucosal cytokine compositions and uses thereof

Country Status (15)

Country Link
EP (1) EP1027068B1 (xx)
CN (1) CN1259104C (xx)
AR (1) AR015956A1 (xx)
AT (1) ATE313331T1 (xx)
AU (1) AU762360B2 (xx)
CA (1) CA2312906A1 (xx)
DE (1) DE69832902T2 (xx)
ES (1) ES2252859T3 (xx)
FR (1) FR2769505B1 (xx)
HK (1) HK1030150A1 (xx)
IL (1) IL136604A0 (xx)
NZ (1) NZ504955A (xx)
TW (1) TWI233357B (xx)
WO (1) WO1999018992A1 (xx)
ZA (1) ZA989206B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ425699A0 (en) 1999-11-25 1999-12-23 University Of Newcastle Research Associates Limited, The A method of treating a malignancy in a subject and a pharmaceutical composition for use in same
GB0001710D0 (en) * 2000-01-25 2000-03-15 Pharma Pacific Pty Ltd Therapeutic treatment
AUPR381601A0 (en) * 2001-03-19 2001-04-12 Monash University Method of treating respiratory conditions
EP1250933A1 (en) * 2001-04-17 2002-10-23 Istituto Superiore di Sanità Vaccines including as an adjuvant high dose type I IFN
ATE407698T1 (de) 2003-04-23 2008-09-15 Medarex Inc Zusammensetzungen und verfahren zur behandlung von entzündlicher darmerkrankung
KR101335079B1 (ko) 2004-06-21 2013-12-12 메다렉스, 엘.엘.시. 인터페론 알파 수용체 1 항체 및 그의 용도
CN101861162A (zh) * 2007-03-14 2010-10-13 高世英 通过粘膜给予白介素治疗癌症的方法
DE102007014752A1 (de) 2007-03-28 2008-10-02 Dusek, Niels, Dr. Verwendung von humanidentischem oder humanaequivalentem rekombinantem Interleukin-2 (heqlL-2) als Therapeutikum in der Human- und Veterinärmedizin
CN102462837B (zh) 2010-11-19 2016-08-03 生物林格斯Ip有限公司 抗炎组合物
US9669071B2 (en) 2011-03-11 2017-06-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for stimulating T lymphocytes with IL-2
CN103732241A (zh) 2011-03-11 2014-04-16 公共事业救济局-巴黎医院 低剂量il-2用于治疗自身免疫相关病症或炎性病症的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286748A (en) * 1981-01-05 1994-02-15 Eby Iii George A General method of shortening the duration of common colds by application of medicaments to tissues of oral cavity
ZA878295B (en) * 1986-11-06 1988-05-03 Amarillo Cell Culture Co. Inc. Treatment of immuno-resistant disease
US5449515A (en) * 1989-11-21 1995-09-12 University Of Melbourne Anti-inflammatory compositions and methods
US5215741A (en) * 1990-10-30 1993-06-01 Amarillo Cell Culture Company, Incorporated Method for prevention of parasite infections
AU9161591A (en) * 1990-12-19 1992-07-22 Schering Corporation Use of il-4 to enhance immune response to immunogens in vaccines
US5496559A (en) * 1991-04-08 1996-03-05 Sumitomo Pharmaceuticals Company, Limited Porous solid formulations containing proteinaceous physiologically active substances
AU1748697A (en) * 1996-01-19 1997-08-11 Mcgill University Hepatitis pretreatment composition and method

Also Published As

Publication number Publication date
FR2769505B1 (fr) 2000-06-30
CN1259104C (zh) 2006-06-14
ATE313331T1 (de) 2006-01-15
TWI233357B (en) 2005-06-01
EP1027068B1 (en) 2005-12-21
DE69832902T2 (de) 2006-08-10
WO1999018992A1 (en) 1999-04-22
FR2769505A1 (fr) 1999-04-16
ES2252859T3 (es) 2006-05-16
CN1281368A (zh) 2001-01-24
AU762360B2 (en) 2003-06-26
ZA989206B (en) 1999-04-12
CA2312906A1 (en) 1999-04-22
AR015956A1 (es) 2001-05-30
AU9455698A (en) 1999-05-03
HK1030150A1 (en) 2001-04-27
DE69832902D1 (de) 2006-01-26
EP1027068A1 (en) 2000-08-16
NZ504955A (en) 2002-11-26

Similar Documents

Publication Publication Date Title
HK1019774A1 (en) Etching composition and use thereof.
HUP0004398A3 (en) Alpha-aryl-n-alkylnitrones and pharmaceutical compositions containing the same
HUP0103562A3 (en) Novel compositions and use
HK1033653A1 (en) Synergistic composition and use thereof
GB9717598D0 (en) Novel composition and use
AU2972597A (en) Compositions and uses thereof
HUP0101701A3 (en) Substituted betha-alanines and pharmaceutical compositions comprising them
EP1113815A4 (en) IMMUNOGENIC COMPOSITIONS AND USES THEREOF
HK1030150A1 (en) Oromucosal cytokine compositions and uses thereof
EP1036165A4 (en) HUMAN RNASE, COMPOSITIONS AND USES THEREOF
SG71754A1 (en) Copolymer and copolymer composition
HUP9800596A3 (en) Antifungal compositions and use thereof
HUP0000460A3 (en) Imidazopyridazines and pharmaceutical compositions thereof
AP9901675A0 (en) Pharmaceutical compositions or tizoxanide and nitazoxanide
PL330820A1 (en) Novel radiopharmaceutic compositions and matrices and their application
GB9608505D0 (en) Compositions processes and uses
GB9718636D0 (en) Novel composition and use
EP0998578A4 (en) SEL-10 AND USES OF SEL-10
SG100797A1 (en) Semiconductive ceramic composition and semiconductive ceramic element using the same
AP2002002429A0 (en) Novel composition and emulsifier
AU2164400A (en) Flint compositions and uses thereof
GB9722392D0 (en) Composition and use
GB9706758D0 (en) Compositions and their use
GB9722390D0 (en) Composition and use
GB9712961D0 (en) Composition and use